IMT Feedback

    Did the IMT help you in finding the resource you needed?

    Your feedback helps us improve the toolkit in the future.

    Are you experiencing difficulties? Please include information on your search query and used browser



    Input this code: captcha

    Skip to content
    • Homepage
    • Browse Resources
    • Questions
    • Use Cases
    • Collections
      • Clinical Trials Toolkit
      • Orphan Drug Guide
      • Mentoring packages
      • EJPRD online courses
      • EBStatMax
      • Advisory Committee for Therapeutics Toolkit
      • Together4RD Toolkit
    • Services
    • My IMT
    ERDERA IMT

    Browse Resources

    Categories

    • Funding
      • Private
        • Foundations
        • Loans
        • Grant
        • Fellowship
        • Venture Capital/Angel Investment
        • Incubators/Accelerators
        • Awards
        • Crowdfunding
      • Public
        • Incubators/Accelerators
        • Fellowship
        • Awards
        • Grant
        • Loans
    • Translational Project Management
      • Technology Transfer Offices (TTOs)
        • What is technology transfer?
        • TTO and Intellectual Property management
        • TTO and Commercialisation
      • Project Management
        • Data Management
        • Project Management Manual
      • TPP
      • Reverse Planning Approach
      • Consulting & Advice
        • TREAT-NMD Advisory Committee for Therapeutics (TACT)
    • Research and Drug Development
      • Disease Model
        • In silico
        • Cell Model
        • Animal Model
      • Disease or Translational Resources
        • Patient registries
        • Data Bases and Tools
        • Natural History
        • Patients Information
        • Target Patient Value Profile
        • Networks
        • Biobanks
        • Biomarkers
      • Drug Discovery
        • Small Molecules
        • Advanced Therapies
        • Target Validation
        • High Throughput Screening (HTS)
        • Bioassays
        • Drug Repurposing
      • Data Collection
        • Patient Registries
      • Clinical Development
        • Safety Reporting
        • Clinical Trial Design
        • Endpoints
        • Patients
    • Regulatory Science
      • Biologicals
      • Early access support
        • Nan-byo designation
        • Orphan medicines
        • Medical Devices
        • Scientific Advice
        • Orphan drug designation
        • SME Office
        • Paediatric medicines
        • Advanced Therapy
        • Patient Advice
        • Scientific guidelines
      • Preclinical Studies
        • Efficacy
      • Clinical Development
        • Endpoints
        • Good Clinical Practices
        • Compassionate Use
      • Marketing Authorisation
        • FDA Priority Review Vaucher (PRV)
        • EU Marketing Authorisation Road Map
        • Orphan Medicines Procedure
        • Advanced Therapy procedure
        • Paediatric Medicines Procedure
        • Conditional Approval
        • Exceptional Circumstances
        • Accelerated Assessment
      • Ethic and Legal Issues
        • Data protection and confidentiality
        • Clinical Studies
        • Clinical Trials
        • Orphan medicines
        • Genetics
        • Paediatrics
        • Advanced Therapies
        • Animal Welfare
      • HTA
        • National HTA Bodies
        • European HTA Bodies
        • International HTA Bodies
    • Intellectual Property
      • Basics of Intellectual Property
        • Types of Intellectual Property
        • Intellectual Property Teaching Kit
        • European IP Helpdesk
        • Freedom to Operate (FTO)
      • Patent Filing
        • International Patent Cooperation Treaty (PCT) Route
        • European Route
        • American Route
      • Patent Search
        • Patentscope
        • Espacenet
      • Market Exclusivity
        • Incentives in Orphan Medicines
        • Incentives in Paediatric Medicines
      • Commercialisation

    Subjects

    All SubjectsHuman RightsGenetic TestingGenetic Testing and Screening

    Regions

    • All regions
      • International
      • Europe

    Genetics

    1. Showing 2 results for:
    2. Regulatory Science
    3. Ethic and Legal Issues
    4. Genetics
    All Subjects

    Council of the European Union. Recommendations R (92) 3 on the Genetic Testing and Screening for Health Care Purposes (CoE 1992).

    Published by Council of Europe

    Genetic Testing and Screening

    The major general aim of this document is to contribute to the discussion of a consensus definition of Genetic testing and of its global applicability.

    View this resource Bookmark this resource

    Council of the European Union. Additional Protocol to the Convention on Human Rights and Biomedicine Concerning Genetic Testing for Health Purposes, 2008.

    Published by Council of Europe

    Genetic TestingHuman Rights

    The first international legally binding instrument concerning genetic testing for health purposes was adopted by the Committee of Ministers of the Council of Europe.

    View this resource Bookmark this resource
    The Innovation Management Toolbox was originally developed through funding from the EJP RD project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 825575. The continued development and maintenance of the Toolbox are now supported by the ERDERA partnership, funded under the European Union’s Horizon Europe Research & Innovation programme, grant agreement No. 101156595.
    © 2026 ERDERA IMT | GetYos IT